FLOT Chemotherapy Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
AstraZeneca1

Indications

Cancer2
Gastroesophageal Adenocarcinoma1
Resectable Esophagogastric Adenocarcinoma1
Gastric Adenocarcinoma1
Esophagogastric Junction Adenocarcinoma1

Other1 trial

A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma

Phase 1

Newark, Delaware1 trial

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Research Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.